Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 151, Issue 3 II SUPPL., 1995, Pages

  Knowles, Michael R ^a   Olivier, K ^a   Noone, P ^a   Boucher, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; AMILORIDE; CHLORIDE CHANNEL; CHLORIDE ION; CYCLIC AMP; ELASTASE; NUCLEOTIDE DERIVATIVE; SODIUM CHANNEL BLOCKING AGENT; SODIUM ION; TRANSMEMBRANE CONDUCTANCE REGULATOR; URIDINE TRIPHOSPHATE;

BRONCHIECTASIS; CELL MEMBRANE TRANSPORT; CHLORIDE TRANSPORT; CLINICAL TRIAL; CONFERENCE PAPER; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN CELL; MUCOCILIARY CLEARANCE; NONHUMAN; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY FAILURE; SODIUM ABSORPTION; SODIUM TRANSPORT; WATER TRANSPORT;

EID: 0028929841     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/151.3_pt_2.s65     Document Type: Conference Paper

References (41)

1. Davis, P. B. 1993. Pathophysiology of the lung disease in cystic fibrosis. In P. B. Davis, editor. Lung Biology in Health and Disease; Cystic Fibrosis, vol. 64. Marcel Dekker, Inc., New York. 193-218.
2. Stutts, M. J., M. R. Knowles, T. Chinet, and R. C. Boucher. 1991. Abnormal ion transport in cystic fibrosis airway epithelium. In S. G. Farmer and D. W. P. Hay, editors. The Airway Epithelium: Physiology, Pathophysiology, and Pharmacology. Marcel Dekker, Inc., New York. 301-334.
3. Boucher, R. C. 1994. Human airway ion transport: State of the Art-Part 1. Am. J. Respir. Crit. Care Med. 150:271-281.
4. Boucher, R. C. 1994. Human airway ion transport: State of the Art-Part 2. Am. J. Respir. Crit. Care Med. 150:581-593.
5. Boat, T. F., M. J. Welsh, and A. L. Beaudet. 1989. Cystic fibrosis. In C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle, J. B. Standbury, J. B. Wyngaarden, and D. S. Fredrickson, editors. The Metabolic Basis of Inherited Disease, 6th ed. McGraw-Hill Information Services Company, New York. 2649-2680.
6. Turpin, S. V., and M. R. Knowles. 1993. Treatment of pulmonary disease in cystic fibrosis. In P. B. Davis, editor. Lung Biology in Health and Disease; Cystic Fibrosis, vol 64. Marcel Dekker, Inc., New York. 277-344.
7. Kilburn, K. H. 1968. A hypothesis for pulmonary clearance and its implications. Am. Rev. Respir. Dis. 98:449-463.
8. Knowles, M., G. Murray, J. Shallal, F. Askin, V. Ranga, J. Gatzy, and R. Boucher. 1984. Bioelectric properties and ion flow across excised human bronchi. J. Appl. Physiol. 56:868-877.
9. Waltner, W. E., R. C. Boucher, J. T. Gatzy, and M. R. Knowles. 1987. Pharmacotherapy of airway disease in cystic fibrosis. Trends Pharmacol. Sci. 8:316-320.
10. + transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78:1245-1252.
11. + permeability in cystic fibrosis human primary cell cultures. J. Physiol. (Lond.) 405:77-103.
12. Welsh, M. J., M. P. Anderson, D. P. Rich, L. S. Ostedgaard, R. J. Gregory, S. H. Cheng, and A. Smith. 1993. Cystic fibrosis, CFTR, and abnormal electrolyte transport. In P. B. Davis, editor. Lung Biology in Health and Disease; Cystic Fibrosis, vol. 64. Marcel Dekker, Inc., New York. 29-52.
13. Smith, J. J., and M. J. Welsh. 1993. Fluid and electrolyte transport by cultured human airway epithelia. J. Clin. Invest. 91:1590-1597.
14. Oh, Y. S., and D. J. Benos. 1992. Amiloride-sensitive sodium channels. In E. J. Cragoe, Jr., T. R. Kleyman, and L. Simchowitz, editors. Amiloride and its Analogs: Unique Cation Transport Inhibitors. VCH Publishers, Inc., New York. 41-56.
15. - pathways in cultured human airway epithelium. Am. J. Physiol. 256:C1033-C1044.
16. Willumsen, N. J., and R. C. Boucher. 1989. Shunt resistance and ion permeabilities in normal and cystic fibrosis airway epithelium. Am. J. Physiol. 256:C1054-C1063.
17. Jiang, C., W. E. Finkbeiner, J. H. Widdicombe, P. B. McCray, Jr., and S. S. Miller. 1993. Altered fluid transport across airway epithelium in cystic fibrosis. Science 262:424-427.
18. Clarke, L. L., B. R. Grubb, S. E. Gabriel, O. Smithies, B. H. Koller, and R. C. Boucher. 1992. Defective epithelial chloride transport in a gene targeted mouse model of cystic fibrosis. Science 257:1125-1128.
19. Quinton, P. M. 1990. Cystic fibrosis: a disease in electrolyte transport. FASEB J. 4:2709-2717.
20. Boucher, R. C., E. H. C. Cheng, A. M. Paradiso, M. J. Stutts, M. R. Knowles, and H. S. Earp. 1989. Chloride secretory response of cystic fibrosis human airway epithelia: preservation of calcium but not protein kinase C- and A-dependent mechanisms. J. Clin. Invest. 84:1424-1431.
21. Anderson, M. P., R. J. Gregory, S. Thompson, D. W. Souza, S. Paul, R. C. Mulligan, A. E. Smith, and M. J. Welsh. 1991. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253:202-205.
22. Knowles, M. R., J. Gatzy, and R. Boucher. 1981. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305:1489-1495.
23. Tomkiewicz, R. P., E. M. App, J. G. Zayas, O. Ramirez, N. Church, R. C. Boucher, M. R. Knowles, and M. King. 1993. Amiloride inhalation therapy in cystic fibrosis: influence on ion content, hydration and rheology of sputum. Am. Rev. Respir. Dis. 148:1002-1007.
24. App, E. M., M. King, R. Helfesrieder, D. Kohler, and H. Matthys. 1990. Acute and long-term amiloride inhalation in cystic fibrosis lung disease: a rational approach to cystic fibrosis therapy. Am. Rev. Respir. Dis. 141:605-612.
25. Benali, R., D. Pierrot, J. M. Zahm, S. G. de Bentzmann, A. Moreau, and E. Puchell. 1993. Effect of extracellular ATP and UTP on fluid transport by human upper airway epithelial cells in culture. Am. Rev. Respir. Dis. 147:A1009. (Abstract)
26. Knowles, M. R., M. J. Stutts, A. Spock, N. Fischer, J. T. Gatzy, and R. C. Boucher. 1983. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science 221:1067-1070.
27. Kohler, D., E. App, M. Schmitz-Schumann, G. Weurtemberger, and H. Matthys. 1986. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibrosis. Eur. J. Respir. Dis. (Suppl. 146)69:319-326.
28. Knowles, M. R., N. L. Church, W. E. Waltner, J. T. Gatzy, and R. C. Boucher. 1992. Amiloride in cystic fibrosis: safety, pharmacokinetics, and efficacy in the treatment of pulmonary disease. In E. J. Cragoe, Jr., T. R. Kleyman, and L. Simchowitz, editors. Amiloride and its analogs: unique cation transport inhibitors. VCH Publishers, Inc., New York. 301-316.
29. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankaskas, P. H. Gilligan, M. King, L. J. Edwards, R. W. Helms, and R. C. Boucher. 1990. A pilot study of aerosolized amiloride for the treatment of cystic fibrosis lung disease. N. Engl. J. Med. 332:1189-1194.
30. Rolfe, M. W., S. L. Kunkel, B. Rowens, T. J. Standiford, E. J. Cragoe, Jr., and R. M. Strieter. 1992. Suppression of human alveolar macrophage-derived cytokines by amiloride. Am. J. Respir. Cell Mol. Biol. 6:576-582.
31. Gallo, R. L. 1990. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 323.996-997. (Letter to the editor)
32. Knowles, M. R., N. L. Church, W. E. Waltner, J. R. Yankaskas, P. Gilligan, M. King, L. J. Edwards, R. W. Helms, and R. C. Boucher. 1990. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 323:997-998. (Response to the editor)
33. Wood, R. E., K. C. Blair, E. Liao, D. Becerra, P. W. Cheng, N. Church, and W. Anderson. 1992. Deposition of amiloride aerosol in the airways of children with CF, ages 4-11 years. Late-Breaking Science, North American CF Conference. 9A. (Abstract)
34. Mason, S. J., A. M. Paradiso, and R. C. Boucher. 1991. Regulation of transepithelial ion transport and intracellular calcium by extracellular adenosine triphosphate in human normal and cystic fibrosis airway epithelium. Br. J. Pharmacol. 103:1649-1656.
35. Knowles, M. R., L. L. Clark, and R. C. Boucher. 1991. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 325:533-538.
36. Brown, H. A., E. R. Lazarowski, R. C. Boucher, and T. K. Harden. 1991. Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5-nucleotide receptor in human airway epithelial cells. Mol. Pharmacol. 40:648-655.
37. Clark, L. L., and R. C. Boucher. 1992. Chloride secretory response to extracellular ATP in normal and cystic fibrosis nasal epithelia. Am. J. Physiol. 263:C348-C356.
38. Stutts, M. J., T. C. Chinet, S. J. Mason, J. M. Fulton, L. L. Clarke, and R. C. Boucher. 1992. Regulation of chloride channels in normal and cystic fibrosis airway epithelial cells by extracellular ATP. Proc. Natl. Acad. Sci. U.S.A. 89:1621-1625.
39. Davis, C. W., M. L. Dowell, M. I. Lethem, and M. Van Scott. 1992. Goblet cell degranulation in isolated canine tracheal epithelium: response to exogenous ATP, ADP, and adenosine. Am. J. Physiol. 262:C1313-C1323.
40. Mason, S. J., K. N. Olivier, D. Bellinger, D. J. Meuten, P. D. Pare, M. R. Knowles, and R. C. Boucher. 1993. Studies of absorption and acute and chronic effects of aerosolized and parenteral uridine 5′-triphosphate (UTP) in animals. Am. Rev. Respir. Dis. 147:A27. (Abstract)
41. Olivier, K. N., K. H. Hohneker, P. G. Noone, R. C. Boucher, and M. R. Knowles. 1993. Aerosolized uridine 5′-triphosphate (UTP) as a potential new therapy for cystic fibrosis (CF) lung disease: acute safety studies in humans. Am. Rev. Respir. Dis. 147:A28. (Abstract)